Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the quick ratio (acid-test) high or low?
The quick ratio (acid-test) of 7.27 is 42% below its 5-year average of 12.45, near the low end of its 5-year range (6.04–22.14).
As of the fiscal period ended Tuesday, June 30, 2026. 32.05% below its 12-month average of 10.70.
Reported quarterly quick ratio; no daily interpolation. Q1 FY2027 (2026-06-30): 7.27.
QUICK RATIO (ACID-TEST)
7.27
QUICK RATIO (ACID-TEST) AVG TTM
10.70
QUICK RATIO (ACID-TEST) AVG 3Y
9.93
QUICK RATIO (ACID-TEST) AVG 5Y
12.45
QUICK RATIO (ACID-TEST) AVG 10Y
N/A
QUICK RATIO (ACID-TEST) AVG 15Y
N/A
QUICK RATIO (ACID-TEST) AVG 20Y
N/A
CURRENT VS TTM AVG
-32.05%
CURRENT VS 3Y AVG
-26.78%
CURRENT VS 5Y AVG
-41.63%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
3.25
median of 789 covered companies
CURRENT VS SECTOR MEDIAN
+123.65%
vs the sector median at left
Immunovant, Inc.
Market Cap
$6.55B
Quick Ratio (Acid-Test)
7.27
TTM Avg
10.70
3Y Avg
9.93
5Y Avg
12.45
Market Cap
$6.57B
Quick Ratio (Acid-Test)
0.87
TTM Avg
1.56
3Y Avg
2.48
5Y Avg
3.39
Market Cap
$6.50B
Quick Ratio (Acid-Test)
2.89
TTM Avg
3.87
3Y Avg
3.94
5Y Avg
3.31
Market Cap
$6.49B
Quick Ratio (Acid-Test)
1.44
TTM Avg
1.17
3Y Avg
1.11
5Y Avg
1.26
Market Cap
$6.66B
Quick Ratio (Acid-Test)
0.89
TTM Avg
1.19
3Y Avg
1.21
5Y Avg
1.11
Market Cap
$6.25B
Quick Ratio (Acid-Test)
3.20
TTM Avg
3.62
3Y Avg
5.38
5Y Avg
6.45
Market Cap
$5.94B
Quick Ratio (Acid-Test)
30.96
TTM Avg
15.27
3Y Avg
11.45
5Y Avg
10.17
| NAME | MARKET CAP | QUICK RATIO (ACID-TEST) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Immunovant, Inc. (IMVT) | $6.55B | 7.27 | 10.70 | 9.93 | 12.45 |
| Hims & Hers Health, Inc. (HIMS)vs › | $6.57B | 0.87 | 1.56 | 2.48 | 3.39 |
| Lantheus Holdings, Inc. (LNTH)vs › | $6.50B | 2.89 | 3.87 | 3.94 | 3.31 |
| Amneal Pharmaceuticals, Inc. (AMRX)vs › | $6.49B | 1.44 | 1.17 | 1.11 | 1.26 |
| Chemed Corporation (CHE)vs › | $6.66B | 0.89 | 1.19 | 1.21 | 1.11 |
| Rhythm Pharmaceuticals, Inc. (RYTM)vs › | $6.25B | 3.20 | 3.62 | 5.38 | 6.45 |
| Alkermes plc (ALKS)vs › | $7.00B | 1.85 | 2.92 | 2.56 | 2.40 |
| GRAIL Inc. (GRAL)vs › | $6.02B | 10.74 | 11.09 | 6.26 | 5.77 |
| Ligand Pharmaceuticals Incorporated (LGND)vs › | $5.94B | 30.96 | 15.27 | 11.45 | 10.17 |
| Iovance Biotherapeutics, Inc. (IOVA)vs › | $5.91B | 3.82 | 3.07 | 3.52 | 5.23 |
Quick Ratio
7.27
Excludes inventory
Current Ratio
7.27
Includes inventory
Quick Ratio = (Current Assets − Inventory) / Current Liabilities
The quick ratio is a stricter liquidity measure that excludes inventory, showing the ability to meet short-term obligations with the most liquid assets.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | QUICK RATIO (ACID-TEST) |
|---|---|
| 2026-06-30 | 7.27 |
| 2026-03-31 | 9.09 |
| 2025-12-31 | 15.74 |
| 2025-09-30 | 9.07 |
| 2025-06-30 | 12.32 |
| 2025-03-31 | 11.16 |
| 2024-12-31 | 6.04 |
| 2024-09-30 | 7.61 |
| 2024-06-30 | 13.08 |
| 2024-03-31 | 13.70 |
| 2023-12-31 | 22.14 |
| 2023-09-30 | 7.23 |
| 2023-06-30 | 6.82 |
| 2023-03-31 | 9.34 |
| 2022-12-31 | 11.01 |
| 2022-09-30 | 13.41 |
| 2022-06-30 | 21.48 |
| 2022-03-31 | 11.52 |
| 2021-12-31 | 14.87 |
| 2021-09-30 | 19.86 |
| 2021-06-30 | 18.75 |
| 2021-03-31 | 21.79 |
| 2020-12-31 | 26.05 |
| 2020-09-30 | 35.15 |
| 2020-06-30 | 14.64 |
| 2020-03-31 | 7.12 |
| 2019-12-31 | 8.58 |
| 2019-09-30 | 5.22 |
| 2019-06-30 | 22.77 |
| 2019-03-31 | 0.49 |
| 2018-12-31 | 0.00 |
| 2018-09-30 | 0.00 |
| 2018-06-30 | 0.00 |
